Deutsche Bank Upgrades ResMed (RMD) to Buy

August 2, 2013 8:01 AM

Deutsche Bank upgraded ResMed (NYSE: RMD) from Hold to Buy with a price target of $54.00 (from $46.00). Analyst David ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found